Funding Round Overview

Update
Founded:
February 8, 2009
Headquarters:
Cambridge
Funding:
$5.40M
Categories:
Biotechnology

PneumaCare develops products for diagnosis and monitoring of respiratory diseases using novel 3D imaging technology.

Description

Update

PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a number of medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device.

PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development... See More

Current Team (9)

Update

Products (2)

Update

Funding Rounds (9) - $5.40M

Update

Investors (10)

Update

Offices/Locations (3)

Update
  • Clinical Demo Facility

    Great Ormond Street Hospital

    London, WC1N 1LE

    GBR

  • Clinical Demo Facility

    Addenbrooke's Hospital

    Hills Road

    Cambridge, CB2 0QQ

    GBR

  • Cambridge Office

    St. John’s Innovation Centre

    Cowley Road

    Cambridge, CB4 0WS

    GBR